Literature DB >> 27554819

Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2.

Kelly A Orgel1, Shiteng Duan2, Benjamin L Wright3, Soheila J Maleki4, John C Wolf4, Brian P Vickery5, A Wesley Burks5, James C Paulson2, Mike D Kulis6, Matthew S Macauley7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27554819      PMCID： PMC5222808          DOI： 10.1016/j.jaci.2016.06.053

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

1.  The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.

Authors:  M Kulis; X Chen; J Lew; Q Wang; O P Patel; Y Zhuang; K S Murray; M W Duncan; H S Porterfield; A W Burks; S C Dreskin
Journal:  Clin Exp Allergy       Date:  2012-02       Impact factor: 5.018

2.  State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous.

Authors:  Stacie M Jones; A Wesley Burks; Christophe Dupont
Journal:  J Allergy Clin Immunol       Date:  2014-02       Impact factor: 10.793

Review 3.  Diagnostic accuracy of specific IgE to components in diagnosing peanut allergy: a systematic review.

Authors:  R J B Klemans; H van Os-Medendorp; M Blankestijn; C A F M Bruijnzeel-Koomen; E F Knol; A C Knulst
Journal:  Clin Exp Allergy       Date:  2015-04       Impact factor: 5.018

Review 4.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

5.  Suppression of the immunologic response to peanut during immunotherapy is often transient.

Authors:  Mark Gorelik; Satya D Narisety; Anthony L Guerrerio; Kristin L Chichester; Corinne A Keet; Anja P Bieneman; Robert G Hamilton; Robert A Wood; John T Schroeder; Pamela A Frischmeyer-Guerrerio
Journal:  J Allergy Clin Immunol       Date:  2014-12-24       Impact factor: 10.793

6.  Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis.

Authors:  Matthew S Macauley; Fabian Pfrengle; Christoph Rademacher; Corwin M Nycholat; Andrew J Gale; Annette von Drygalski; James C Paulson
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

7.  IgE cross-reactivity between the major peanut allergen Ara h 2 and the nonhomologous allergens Ara h 1 and Ara h 3.

Authors:  Merima Bublin; Maria Kostadinova; Christian Radauer; Christine Hafner; Zsolt Szépfalusi; Eva-Maria Varga; Soheila J Maleki; Karin Hoffmann-Sommergruber; Heimo Breiteneder
Journal:  J Allergy Clin Immunol       Date:  2013-03-05       Impact factor: 10.793

8.  Heterogeneous responses and cross reactivity between the major peanut allergens Ara h 1, 2,3 and 6 in a mouse model for peanut allergy.

Authors:  Joost J Smit; Maarten T Pennings; Karina Willemsen; Manon van Roest; Els van Hoffen; Raymond H Pieters
Journal:  Clin Transl Allergy       Date:  2015-03-23       Impact factor: 5.871
  8 in total
  17 in total

Review 1.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

2.  Antigenic Liposomes for Generation of Disease-specific Antibodies.

Authors:  Kyle J Bednar; Lakeya Hardy; Johanna Smeekens; Dharmendra Raghuwanshi; Shiteng Duan; Mike D Kulis; Matthew S Macauley
Journal:  J Vis Exp       Date:  2018-10-25       Impact factor: 1.355

Review 3.  Immune mechanisms of oral immunotherapy.

Authors:  Michael D Kulis; Sarita U Patil; Erik Wambre; Brian P Vickery
Journal:  J Allergy Clin Immunol       Date:  2017-12-26       Impact factor: 10.793

Review 4.  Novel vaccines: Technology and development.

Authors:  Sarita U Patil; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2018-06-30       Impact factor: 10.793

5.  Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec-Engaging Tolerogenic Liposomes.

Authors:  Lijuan Pang; Matthew S Macauley; Britni M Arlian; Corwin M Nycholat; James C Paulson
Journal:  Chembiochem       Date:  2017-04-04       Impact factor: 3.164

6.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

Review 7.  Eosinophil and mast cell Siglecs: From biology to drug target.

Authors:  Jeremy A O'Sullivan; Alan T Chang; Bradford A Youngblood; Bruce S Bochner
Journal:  J Leukoc Biol       Date:  2020-01-22       Impact factor: 4.962

8.  Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.

Authors:  Kyle J Bednar; Elena Shanina; Romain Ballet; Edward P Connors; Shiteng Duan; Joana Juan; Britni M Arlian; Michael D Kulis; Eugene C Butcher; Wai-Ping Fung-Leung; Tadimeti S Rao; James C Paulson; Matthew S Macauley
Journal:  J Immunol       Date:  2017-09-29       Impact factor: 5.422

9.  Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B-Cell Lymphoma Therapy.

Authors:  Senlian Hong; Chenhua Yu; Peng Wang; Yujie Shi; Weiqian Cao; Bo Cheng; Digantkumar G Chapla; Yuanhui Ma; Jie Li; Emily Rodrigues; Yoshiki Narimatsu; John R Yates; Xing Chen; Henrik Clausen; Kelly W Moremen; Matthew Scott Macauley; James C Paulson; Peng Wu
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-14       Impact factor: 15.336

10.  Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergy.

Authors:  Kelly Orgel; Johanna M Smeekens; Ping Ye; Lauren Fotsch; Rishu Guo; Darla R Miller; Fernando Pardo-Manuel de Villena; A Wesley Burks; Martin T Ferris; Michael D Kulis
Journal:  J Allergy Clin Immunol       Date:  2018-10-19       Impact factor: 10.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.